# VIP inhaled for COVID-19: hospital stay and lung CT

Source: https://pepvault.app/research/vip-esendagli-2025

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [VIP](https://pepvault.app/research#vip)

Randomized trial · people

# VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In one small human trial, inhaled aviptadil added to standard care was well tolerated and tied to shorter hospital stays and better lung CT scores in COVID-19 patients.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 80
- **Published:** 2025
- **Journal:** Med Princ Pract

## What they tested

The team tested whether inhaled aviptadil, added to standard care, sped recovery in adults hospitalized with COVID-19.

## How the study was done

A randomized, double-blind, placebo-controlled trial in 80 hospitalized adults with COVID-19 at 9 centers. Patients were split evenly between inhaled aviptadil and placebo (a dummy treatment), both on top of standard care, and the main measure was time to discharge within 30 days.

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Average time to discharge was 7.8 days with aviptadil and 10 days with placebo (p = 0.049). On the modified Borg scale, a rating of how breathless patients felt, scores did not differ by group on day 3 but were lower with aviptadil on day 7 (p = 0.033). Lung damage scores on CT scans were similar on day 1, and improvement by day 28 was greater with aviptadil (p = 0.028). Deaths were 5.1% with aviptadil and 12.2% with placebo, and no patient dropped out because of side effects.

## What it doesn’t show

This was a small trial of 80 patients, and the gap in time to discharge fell just under the usual cutoff for statistical significance. It covered only adults hospitalized with COVID-19 and followed them for about a month, so it shows nothing about other conditions or longer-term effects.

## The paper

Esendagli et al. Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19. Med Princ Pract. 2025.

- [PubMed (PMID 39870064)](https://pubmed.ncbi.nlm.nih.gov/39870064/)
- [The paper (DOI 10.1159/000543773)](https://doi.org/10.1159/000543773)
- [ClinicalTrials.gov (NCT04844580)](https://clinicaltrials.gov/study/NCT04844580)

## The compound

- [VIP: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

## With this study

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Studies

- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [BPC-157 vs VIP](https://pepvault.app/peptides/compare/bpc-157-vs-vip)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on VIP

- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005) Clinical trial · people · 2005
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986) Clinical trial · people · 1986
- [VIP: tear levels rose after laser eye surgery, peaking at 1 week](https://pepvault.app/research/vip-kang-2023) Observational study · people · 2023
- [Every study on VIP](https://pepvault.app/research#vip)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Studies

- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [BPC-157 vs VIP](https://pepvault.app/peptides/compare/bpc-157-vs-vip)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on VIP](https://pepvault.app/research#vip)

## The library

- [VIP](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
